Ergoloid Mesylate

甲磺酸双氢麦角碱

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameErgoloid Mesylate
Drug Alias Name甲磺酰双氢麦角毒Codergocrine MesilateDihydroergotoxine Methanesulfonate甲磺酸二氢麦角碱海特琴 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor antagonists
TargetsAlpha adrenergic receptor
Therapy Area/IndicationsHeadacheDementia
Global Approved IndicationsHeadacheDementia
Approved Indications in ChinaHeadacheDementia
Original Approved Country/TerritoryUnited States
Original Approved Date1953/11/05
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesLek Pharmaceutical And Chemical Company Dd
Inactive CompaniesNovartis Pharma Ag
Active IndicationsHeadacheDementia
Inactive IndicationsN/A

Other Information

ATC CodeC04AE01
Related LinksWikipediaDrugBankKEGG